Evidence map›Paper›PMID 39665026›Full record

ArticlePragmatic and observational research2024

Patient Characteristics, Management, and Outcomes of Adult Asthma in a Singapore Population: Data from the SDG-CARE Asthma Registry.

Mariko Siyue Koh, Sean Shao Wei Lam, Xiaomeng Xu, Jun Tian Wu, Priyan Ratnasingham, Ricco Marsel, Marcus Eng Hock Ong, David Bruce Matchar, Ngiap Chuan Tan, Chian Min Loo

Abstract read
In one paragraph

Article in Pragmatic and observational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Guideline-based asthma treatment in Asia: Insights from a robust time-in-state model.The journal of allergy and clinical immunology. Global · 2025
    Article
  5. Environmental sustainability in asthma: reducing carbon footprint and medication wastage.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mariko Siyue KohDepartment of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.
Sean Shao Wei LamHealth Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.
Xiaomeng XuMedical, GSK, Singapore, Singapore.ORCID 0000-0003-3936-0591
Jun Tian WuHealth Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.
Priyan RatnasinghamMedical, GSK, Singapore, Singapore.ORCID 0009-0006-5233-1989
Ricco MarselMedical, GSK, Singapore, Singapore.
Marcus Eng Hock OngHealth Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.
David Bruce MatcharDuke-NUS Medical School, National University of Singapore, Singapore, Singapore.ORCID 0000-0003-3020-2108
Ngiap Chuan TanDuke-NUS Medical School, National University of Singapore, Singapore, Singapore.ORCID 0000-0002-5946-1149
Chian Min LooDepartment of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Patients with asthma in Singapore often have complex patient journeys, with diagnosis and management across various primary and speciality care settings. Real-world population health data is needed to identify care gaps and inform policies. Patients and Methods: This retrospective, longitudinal cohort study assessed real-world data from adults (aged ≥18 years) with asthma in the SingHealth Chronic Obstructive Pulmonary Disease and Asthma Data Mart, an integrated database of electronic medical records of patients who attended primary and/or speciality care clinics in the SingHealth Regional Health System 01/01/2015-12/31/2020. Patients were indexed by first asthma diagnosis and categorized into cohorts of index year. Patient characteristics, asthma management and outcomes were described during baseline (1-year pre-index) and follow-up periods (1-year post-index). Results: Overall, 21,215 patients were included across 4 cohorts: 2016, N=12,947; 2017, N=3419; 2018, N=2816; 2019, N=2033. Most common baseline asthma medication changed from inhaled corticosteroids (ICS) alone in the 2016 cohort (32.8% [n=4252]) to ICS/long-acting β Conclusion: Health status at first asthma diagnosis improved for each succeeding cohort from 2016 to 2019, along with improvements in patient management and outcomes. This reflects greater awareness of the condition and improved use of medication and referrals in recent years, suggesting policy changes and their implementation, including promotion of disease awareness and adoption of guideline recommendations, may improve asthma outcomes in Singapore.

Indexed as

asthmaasthma controlexacerbationshealth outcomesreal worldSingapore

Identifiers

PMID39665026
PMCPMC11633292

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.